agomab
The IFRS and Reporting Manager will serve as the technical reference point for IFRS and lead the consolidation process to ensure accurate statutory and management reporting. This role involves preparing consolidated financial statements, monitoring accounting standards, and managing the year-end audit while collaborating with senior stakeholders and external auditors. The position focuses on improving the quality, efficiency, and transparency of financial reporting to support the company's growth strategy.
Agomab Therapeutics (Nasdaq: AGMB) is a clinical-stage biopharmaceutical company focused on fibro-inflammation, developing growth factor-modulating therapies to treat fibrotic diseases. The company's pipeline includes Ontunisertib (AGMB-129), AGMB-447, and AGMB-101, with active clinical programs targeting conditions such as fibrostenosing Crohn's disease and idiopathic pulmonary fibrosis. Headquartered in Antwerp, Belgium, Agomab translates deep expertise in growth factor biology into disease-modifying treatments aimed at halting or reversing fibrosis and restoring organ function.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for agomab.
agomab didn’t post a salary, so this is our estimate from similar listings.
Group Reporting Manager Windsor (Hybrid)
Morgan Advanced Materials
Consolidation & Statutory Reporting Specialist (Italian Speaking)
lastminute.com
Consolidation & Statutory Reporting Specialist (Italian Speaking)
lastminute.com
Accountant, Financial reporting
Innergy Consulting Pte
IFRS Manager
kissmyapps
IFRS Reporting Analyst
mgid